Elizabeth Thompson

13PUBLICATIONS
131CO-AUTHORS
Innate immunityMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 27, 2026
IL-6 Blockade with Clazakizumab is Associated with Low Myeloid Cell Activation and Increased Type 2 Immune Responses in Non-survivors of COVID-19.

|Sep 30, 2026
Immunometabolic effects of oral testosterone for castration-resistant prostate cancer in the ACROBAT trial.

|Mar 19, 2026
The combination of a cancer vaccine, pembrolizumab, and stereotactic body radiation in patients with locally advanced pancreatic cancer: a single-arm, phase II study.

Valerie Lee, Apoorvaa S Sachidanand, Christina Rodriguez

|Nov 24, 2025
Mechanisms of sex differences in acute and long COVID sequelae in mice.

Jennifer A Liu, Sabal Chaulagain, Patrick S Creisher

|Nov 21, 2025
Androgen Receptor Drives Polyamine Synthesis, Creating a Vulnerability for Prostate Cancer.

Rajendra Kumar, Sheila Jonnatan, David E Sanin

|May 21, 2025
SARS-CoV-2 induces neutrophil degranulation and differentiation into myeloid-derived suppressor cells associated with severe COVID-19.

Leon L Hsieh, Elizabeth A Thompson, Nirvani P Jairam

Pageof 3

Frequent Collaborators

4 joint publications

Jonathan Powell

3 joint publications

Andrew H Karaba

3 joint publications

Andrea L Cox

3 joint publications

Laura A Sena